Financiële berichten

30/07/2021 ImmuPharma - Board Changes
16/07/2021 ImmuPharma - Board Appointment
28/06/2021 ImmuPharma - 2021 RESULT OF ANNUAL GENERAL MEETING – ALL RESOLUTIONS PASSED
24/06/2021 ImmuPharma - FDA to agree on the Lupzuor™ PK study via a written response to “Type C” meeting as ...
02/06/2021 ImmuPharma - Notice of AGM and posting of Report & Accounts

Top performers

 
 
Laden.... Wacht alsjeblieft even.